pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,729 catalysts · 3,126 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 583 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 97 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-06×clear all
type
  • 8k filing3,126
  • grant1,702
  • device adverse event1,000
  • approval795
  • device 510k621
  • earnings583
device pma
467
  • device recall191
  • phase 2 completion172
  • recall162
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 9, 2026

    50
    ›Feb 9, 2026approval184d agoABSORICA (ISOTRETINOIN) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: SUN PHARM INDS INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval184d agoISOTRETINOIN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval184d agoAMNESTEEM (ISOTRETINOIN) — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval184d agoTRAZODONE HYDROCHLORIDE — FDA approvalTRAZODONE HYDROCHLORIDE

    Sponsor: APOTEX INC. Form: TABLET. Route: ORAL

    full page →TRAZODONE HYDROCHLORIDE →fda approvals ↗
    ›Feb 9, 2026approval184d agoMETHAZOLAMIDE — FDA approvalMETHAZOLAMIDE

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →METHAZOLAMIDE →fda approvals ↗
    ›Feb 9, 2026approval184d agoREGLAN (METOCLOPRAMIDE HYDROCHLORIDE) — FDA approvalmetoclopramide hydrochloride

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →metoclopramide hydrochloride →fda approvals ↗
    ›Feb 9, 2026approval184d agoCLARAVIS (ISOTRETINOIN) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval184d agoISOTRETINOIN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval184d agoABSORICA LD (ISOTRETINOIN) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval184d agoTRAZODONE HYDROCHLORIDE — FDA approvalTRAZODONE HYDROCHLORIDE

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →TRAZODONE HYDROCHLORIDE →fda approvals ↗
    ›Feb 9, 2026approval184d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval184d agoSCOPOLAMINE — FDA approvalscopolamine ER

    Sponsor: RICONPHARMA LLC. Form: SYSTEM. Route: TRANSDERMAL

    full page →scopolamine ER →fda approvals ↗
    ›Feb 9, 2026approval184d agoSCOPOLAMINE — FDA approvalscopolamine ER

    Sponsor: RICONPHARMA LLC. Form: SYSTEM. Route: TRANSDERMAL

    full page →scopolamine ER →fda approvals ↗
    ›Feb 9, 2026approval184d agoSCOPOLAMINE — FDA approvalscopolamine ER

    Sponsor: RICONPHARMA LLC. Form: SYSTEM. Route: TRANSDERMAL

    full page →scopolamine ER →fda approvals ↗
    ›Feb 9, 2026approval184d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: AMNEAL PHARMS NY. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval184d agoISOTRETINOIN — FDA approvalISOTRETINOIN

    Sponsor: AUROBINDO PHARMA. Form: CAPSULE. Route: ORAL

    full page →ISOTRETINOIN →fda approvals ↗
    ›Feb 9, 2026approval184d agoZENATANE (ISOTRETINOIN) — FDA approvalISOTRETINOIN

    Sponsor: DR REDDYS LABS LTD. Form: CAPSULE. Route: ORAL

    full page →ISOTRETINOIN →fda approvals ↗
    ›Feb 9, 2026approval184d agoLIDOCAINE — FDA approvalLIDOCAINE

    Sponsor: USPHARMA. Form: PATCH. Route: TOPICAL

    full page →LIDOCAINE →fda approvals ↗
    ›Feb 9, 2026approval184d agoDIGOXIN — FDA approvalDIGOXIN

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →DIGOXIN →fda approvals ↗
    ›Feb 9, 2026device 510k184d agoVascuTech Medical, LLC — Peel-Away Introducer Sheath (510k cleared)

    Product code: DYB. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 9, 2026device 510k184d agoEdan Instruments, Inc. — Holter ECG and ABP system (HolterABP) (510k cleared)VEECO INSTRUMENTS INC

    Product code: DQK. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 9, 2026device 510k184d agoCeribell, Inc. — Ceribell Instant EEG Headset (510k cleared)Ceribell, Inc.

    Product code: GXY. Advisory committee: Neurology. Type: Abbreviated

    full page →fda device 510k ↗
    ›Feb 9, 2026device pma184d agoExact Sciences Corporation — Cologuard Plus™ (PMA supplement)

    Supplement type: 30-Day Notice. Product code: PHP. Advisory committee: PA. Decision: OK30

    full page →fda device pma ↗
    ›Feb 9, 2026device pma184d agoMedtronic Vascular, Inc. — EverFlex™ Self-Expanding Peripheral Stent System; EverFlex™ Self-Expanding Peripheral Stent with Entrust™ Delivery Syste (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIP. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 9, 2026device recall184d agoReflexion Medical, Inc. device recall (Cls II)

    RefleXion X1 Radiotherapy System Model RXM1000, Part #800-00006-00 — Reason: Due to a radiotherapy medical system software defect, when performing angular roll corrections followed by a repeat localization, the roll corrections applied in the initial localization scan are not carried through to treatment delivery leading to the treatment plan dose being delivered to the incorrect location, potentially a displacement of 5mm or higher, with a 10% to 20% underdose. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 9, 2026device recall184d agoAbbott Diagnostics Scarborough, Inc. device recall (Cls II)

    Product Name: ID NOW" Influenza A & B 2 Model/Catalog Number: 427-000 Software Version: Not Applicable Product Description: Influenza A/B virus nucleic acid IVD, kit, nucleic acid technique Component: Not Applicable — Reason: It was confirmed that the impacted lot has a higher occurrence of invalid rates when compared to the product Instructions for Use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 9, 2026grant184d agoINDIANA UNIVERSITY INDIANAPOLIS — Mechanisms driving reactivated toxoplasmosis in HIV/AIDS co-infection

    AI grant. $384,939. PI: Michael James Holmes

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoTRUDEAU INSTITUTE, INC. — Probing the novel mechanism of action of tuberculocidal compounds

    AI grant. $332,414. PI: Michaelle Chojnacki

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoTUFTS MEDICAL CENTER — Pre- and post-exposure prophylaxis of tick-transmitted babesiosis by the anti...Tufts Medical Center

    AI grant. $506,415. PI: Edouard G Vannier

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — Suppression of T-bet+ B cells in lupus by tryptophan metabolites

    AI grant. $409,750. PI: John D Mountz

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Immunogenetic determinants of response to drug-susceptible tuberculosis treat...University of California San Francisco

    AI grant. $842,888. PI: Sara Suliman

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoFRED HUTCHINSON CANCER CENTER — Statistical Methods for Assessing Immune Correlates of Risk and Protection Us...

    AI grant. $220,000. PI: Youyi Fong

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoTEXAS A&M UNIVERSITY HEALTH SCIENCE CTR — A versatile bimodal QF/QS gene expression system for insect and vertebrate mo...

    AI grant. $416,894. PI: Hubert O Amrein

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoCINCINNATI CHILDRENS HOSP MED CTR — Patient-specific, combinatorial NAMs for gastrointestinal diseases and drug r...

    TR grant. $3,240,000. PI: LEE ARMISTEAD DENSON

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoFEDERATION OF AMER SOC FOR EXPER BIOLOGY — Phase Transitions in Cellular Signaling and Disease

    CA grant. $5,000. PI: Priya R. Banerjee

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoEAST CAROLINA UNIVERSITY — Determining how Yersinia pestis YbX and the competition for host zinc impact ...

    AI grant. $226,500. PI: Roger D Pechous

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Infection-induced cell cycle diversion promotes macrophage inflammatory bioge...

    AI grant. $186,758. PI: Mary O'Riordan

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoBOSTON UNIVERSITY MEDICAL CAMPUS — Mechanisms of the alternative macrophage activation in TB

    AI grant. $245,250. PI: Igor Kramnik

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoMASSACHUSETTS GENERAL HOSPITAL — Mechanistic intersection between placental vascular and newborn neuronal deve...Massachusetts General Hospital

    HD grant. $715,595. PI: Lisa M Bebell

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoMASSACHUSETTS GENERAL HOSPITAL — Mechanistic intersection between placental vascular and newborn neuronal deve...Massachusetts General Hospital

    HD grant. $36,131. PI: Lisa M Bebell

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoUNIVERSITY OF VIRGINIA — Host lipid acquisition and maintenance of the Chlamydia replicative nicheUniversity of Virginia

    AI grant. $717,952. PI: ISABELLE DERRE

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoOHIO STATE UNIVERSITY — Mechanisms of simian arterivirus entry, immune evasion, and zoonotic potential

    AI grant. $790,507. PI: Cody Jay Warren

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoDARTMOUTH-HITCHCOCK CLINIC — Multiplexed reporter platforms for probing the bile acid- nuclear receptor in...

    AI grant. $232,500. PI: Mark Scott Sundrud

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoMASSACHUSETTS GENERAL HOSPITAL — Decoding the neuroimmune control of cutaneous gamma/delta cell function in al...Massachusetts General Hospital

    AI grant. $776,034. PI: Caroline Lauren Sokol

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoUNIVERSITY OF WISCONSIN-MADISON — Multipronged approach to characterize the promiscuity and mechanism of PACE t...

    AI grant. $414,305. PI: Katherine Anne Henzler-Wildman

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Eliciting Th1/Th17 dual responses for vaccine-induced immunity to tuberculosis

    AI grant. $460,625. PI: Rocky Lai

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoOREGON HEALTH & SCIENCE UNIVERSITY — Identifying drug targets in M. abscessus through the application of fluoresce...

    AI grant. $442,758. PI: Kimberly Elizabeth Beatty

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoGORDON RESEARCH CONFERENCES — 2026 Thalamocortical Interactions Gordon Research Conference and Gordon Resea...

    NS grant. $15,000. PI: Solange P Brown

    full page →nih reporter ↗
    ›Feb 9, 2026grant184d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — RISE UP for Breast Cancer 2026University of California San Francisco

    CA grant. $12,500. PI: LAURA J ESSERMAN

    full page →nih reporter ↗
    ›Feb 10, 2026approval183d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →pembrolizumab →fda approvals ↗
    ← prev
    page 3 of 175
    next →
    $CBLL19.55-2.25%
    $VECO59.42+2.95%
    $RDY12.45+2.43%